MycoX™ Removal Mix — Research-Use-Only Mycoplasma Cleanup for Mammalian Cell Culture

Executive overview

MycoX™ Removal Mix is a Research Use Only (RUO) reagent designed to reduce mycoplasma contamination in mammalian cell culture while preserving routine experimental utility. The mix supports short exposure cycles, washout and recovery, and multi-method verification (PCR/qPCR, DNA stain, culture). This page explains mechanism concepts, line-tuning, recurrence prevention, documentation, and quality control—with direct links to .edu/.gov resources for training, reproducibility, and biosafety.

Primary keywords: mycoplasma removal mix, mycoplasma cleanup, cell culture contamination, RUO, qPCR verification, aseptic technique, cell line QA, lab biosafety.
Secondary keywords: monthly screening, quarantine program, antibiotic-free culture, verification assay, culture enrichment, reagent stability, SOP traceability.

Background: why mycoplasma cleanup matters (research context)

Mycoplasma can distort gene expression, alter metabolism, and impact assay readouts, undermining reproducibility. Core, non-clinical training resources:

• NCBI Bookshelf — Cell Culture Basics

• NIH — Rigor & Reproducibility

• CDC — BMBL Biosafety Manual

• USDA NAL — Microbiology Lab Guidelines

• NIST — Measurement Services

• University EHS examples: Stanford, UC Berkeley, UCSF, Princeton, Yale, MIT EHS

What MycoX™ Removal Mix is (concept & compatibility)

• Intent: Rapid mycoplasma cleanup from actively growing mammalian cultures (adherent or suspension) under RUO conditions.

• Concept: Multi-target action against Mollicutes (e.g., Mycoplasma, Acholeplasma) to lower the chance of single-pathway resistance (educational framing; exact composition is proprietary).

• Compatibility: Typical DMEM/EMEM/RPMI with common FBS ranges; validate on your line first.

• Avoid mixing with overlapping, high-dose antibiotics unless the SOP explicitly allows (possible antagonism).

Reference biology & taxonomy (non-clinical):

• NCBI Taxonomy — Mycoplasmatales

• NCBI Bookshelf — Microbiology & Methods

• NIH PMC — Open methods library

Mechanism concepts (educational, non-proprietary)

Cleanup regimens typically combine agents with distinct actions that:

1. Compromise replication or translation in mycoplasma,

2. Penetrate cell culture matrices efficiently,

3. Act in short pulses, followed by washout, to preserve mammalian viability.

Helpful primers on antimicrobial action and lab QA (neutral/educational):

• NCBI Bookshelf — Antimicrobial Agents

• FDA — Science & Research (general methods)

• EPA — Quality Assurance

Standard MycoX™ cleanup workflow (step-by-step, RUO)

Follow your product insert for exact dose and exposure time.

Day 0 — Baseline

• Seed at 30–50% confluence (adherent) or mid-log (suspension).

• Record viability, morphology, passage, media/sera lots.

• Save pre-treatment aliquots for verification (PCR/qPCR or DNA stain).

Days 1–3 — Exposure

• Add MycoX™ Removal Mix at label dose/time.

• Monitor morphology and viability daily; avoid adding unrelated antibiotics.

Day 3/4 — Washout & recovery

• Replace with fresh medium.

• Allow 48–72 h recovery; run interim verification (rapid DNA stain or qPCR).

Days 5–10 — Optional repeat

• If interim data are equivocal, repeat a second exposure with the same settings.

• Return to antibiotic-free medium to assess durability.

Days 10–14 — Final verification

• Run PCR/qPCR (broad multi-species primers) and optionally culture-based enrichment.

• Archive raw data and a short report for the lot file.

Assay resources:

• NCBI — Primer-BLAST

• NIH PMC — qPCR methods

• USDA NAL — Microbiology Guidelines

Verification strategy (use ≥2 orthogonal methods)

Combine two or more from the list below to reduce false calls:

• PCR/qPCR (broad mycoplasma panels; Ct/Cq tracking).

• DNA stains (e.g., Hoechst) to visualize extranuclear puncta (screen-level).

• Culture/enrichment (slower, orthogonal confirmation).

• External lab certificate for audited projects.

Core, non-diagnostic primers:

• NCBI Bookshelf — PCR Basics

• CDC — BMBL (lab safety)

Prevention & recurrence control (programmatic approach)

• Quarantine new lines for ~2 weeks; screen twice before release.

• Antibiotic-free routine culture to avoid masking contamination.

• Authenticate lines; keep pedigrees (source, lot, passage, dates).

• Filter-sterilize additives when compatible.

• Dedicated pipettes/benches for high-risk tasks.

• Monthly screening: qPCR + a quick DNA stain snapshot.

Institutional best practices:

• Harvard EHS — rDNA & lab practices

• MIT — EHS Programs

• Princeton — Biosafety

• Yale — Biosafety

Line-specific tuning and cytotoxicity checks

• Run a mini-panel (3–5 doses × exposure times) on your cell line.

• Track viability (Trypan Blue/ATP), growth curves, morphology.

• Choose the lowest effective regimen that meets verification endpoints.

Assay design primers:

• NCBI Bookshelf — Cell Viability Assays

• NIH — Rigor & Reproducibility

Special scenarios (primary cells, 3D, viral work)

• Primary cells/sensitive lines: shorter exposures, extended recovery.

• Viral packaging (AAV/retro/lenti): complete cleanup first; mycoplasma can depress titers and confound QC.

• Co-cultures/3D matrices: verify penetration; consider repeated short cycles.

Neutral references:

• NCBI GenBank

• NIH PMC — bioprocess/QC literature

• NIST — Bioscience Measurements

Documentation & traceability (QA lot file)

For each cleanup event, maintain a lot history file:

• Cell line ID, passage, incubator, media/sera lots.

• MycoX™ lot, dose, exposure schedule, deviations.

• Verification raw data (Cq values, gels, stain images).

• Final “Ready for Research” sign-off.

QA references:

• EPA — Quality Assurance

• NIH — Data Management & Sharing

Storage, stability, and handling

• Store at label temperature; protect from light and repeated freeze–thaw.

• Aliquot on first thaw for single-use.

• Log open date, min/max temps; dispose per local chemical/biological rules.

General frameworks:

• CDC — BMBL

• USDA NAL — Lab Guidelines

Troubleshooting (quick hits)

Method references:

• NIH PMC — Assay QA/QC

• NCBI Bookshelf — PCR & culture methods

FAQ (RUO, non-diagnostic)

Q1. How many cleanup cycles are typical?
Often 1–2 cycles with verification between cycles; sensitive lines may need shorter, repeated pulses.

Q2. Can I keep prophylactic antibiotics during cleanup?
Prefer antibiotic-free routine culture. Avoid overlapping agents unless your SOP specifies.

Q3. Which verification method is “best”?
Use two orthogonal methods (e.g., qPCR + DNA stain). Consider external confirmation for audited studies.

Q4. Will cleanup affect transfection or viral production?
Finish cleanup before production steps; include washout and recovery to minimize interference.

Q5. How do I prevent reinfection?
Quarantine newcomers, authenticate lines, run monthly screens, dedicate pipettes and reagents by room.

On-page SEO checklist (apply before publishing)

• One H1 (product name) + skimmable H2/H3 blocks.

• Sprinkle primary keywords top/middle/bottom; keep sentences short.

• Add ALT text to images: “mycoplasma-cleanup-workflow,” “qPCR-verification-curve,” “aseptic-technique-bench,” “QA-traceability-log.”

• Internal links to mycoplasma PCR/qPCR kits, DNA stains, cell authentication, sterile filters, pipettes, aseptic-technique blog.

• Add FAQPage schema to target rich results.

Authoritative .edu/.gov references (direct pages)

1. NCBI Bookshelf — Cell Culture Basics

2. NIH — Rigor & Reproducibility

3. CDC — BMBL Biosafety Manual

4. USDA NAL — Microbiology Lab Guidelines

5. NIST — Measurement Services

6. NCBI — Primer-BLAST

7. NIH PMC — Open Methods

8. NCBI — GenBank

9. GEO Datasets

10. Harvard EHS — rDNA & Lab Practices